SMB World Report
SEE OTHER BRANDS

Get your daily news on small business

Regenerative Medicine in Mexico: Advances and Perspectives with GIOSTAR Mexico

GIOSTAR Mexico leads innovation in stem cell therapy, offering safe, personalized treatments for chronic and degenerative diseases.

LOS ALGODONES, BAJA CALIFORNIA, MEXICO, November 6, 2025 /EINPresswire.com/ -- Due to the rise of autoimmune and degenerative diseases, caused by genetics, aging and environmental factors, the amount of people around the world looking for new regenerative medicine treatments to improve their health has been increasing nonstop in recent years.

The Growing Demand for Regenerative Treatments

Among the most studied and applied methods within regenerative medicine is stem cell therapy. Stem cells have the unique ability to self-renew and differentiate into various types of specialized cells, which makes them a focus of ongoing research for tissue repair and disease management.
Mexico has become one of the most recognized destinations for medical tourism in Latin America, offering access to a wide range of medical services, including regenerative medicine procedures performed by certified professionals.

Understanding Stem Cell Therapy

Stem cell-based therapies seek to promote the regeneration of damaged tissues and potentially slow the progression of certain diseases. Institutions in Mexico, such as the Global Institute of Stem Cell Therapy and Research (GIOSTAR), have contributed to this field by developing protocols and conducting clinical applications under local and international standards.

Research and Development in Mexico

Founded by Dr. Anand Srivastava, GIOSTAR Mexico operates facilities in various locations including Los Algodones, Playa del Carmen, and Guadalajara. Their work focuses on combining research in stem cell science with individualized treatment approaches designed to meet specific medical needs.

Conditions that have been studied in the context of stem cell therapy include Parkinson’s disease, arthritis, diabetes, amyotrophic lateral sclerosis (ALS), and autism spectrum disorders.

Their mission is divided into three main aspects:
1. Slow down the symptoms of the condition
2. Stop the progression of the disease
3. Regenerate the damaged areas of the body

Regulatory Framework and Certification

In Mexico, clinics offering regenerative medicine treatments are required to comply with the regulations of the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS), the national health authority. This certification ensures that procedures meet safety and quality standards similar to those applied by the U.S. Food and Drug Administration (FDA).

Patient Experiences and Ongoing Research

Several patients from different countries have traveled to Mexico seeking regenerative therapies, with GIOSTAR Mexico being one of the most sought-after among the public. While individual outcomes vary, these experiences have drawn attention to the potential benefits and limitations of stem cell-based treatments. Continuous research aims to better understand the mechanisms behind these therapies and their long-term effects.

A Field in Constant Evolution

With more than a decade of research and clinical practice, regenerative medicine in Mexico continues to evolve through collaboration among scientists, clinicians, and institutions such as GIOSTAR Mexico. As studies advance, this field holds great promise for developing therapies that may improve health outcomes for patients worldwide.

GIOSTAR Mexico
GIOSTAR Mexico
email us here
Visit us on social media:
Instagram
Facebook
YouTube
TikTok
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions